Phase
Condition
Open Angle Glaucoma
Glaucoma
Treatment
OMNI Surgical System
Latanoprost plus adjunctive glaucoma medication
Clinical Study ID
Ages > 45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female subjects, 45 years or older.
History of uncomplicated cataract surgery and posterior chamber intraocular lens (IOL) implantation without compromise to the lens capsule, zonulardehiscence/rupture or vitreous prolapse, 6 months or more prior to Baseline Visit (pseudophakic subjects), OR, phakic and no anticipated need for cataract surgeryover the study duration.
Under treatment with a topical prostaglandin F2 analog (e.g. latanoprost,travoprost, bimatoprost, tafluprost) either as monotherapy or in combination withone (1) adjunctive medication for a minimum of 6 weeks prior to the Screening visit.
Intraocular pressure (IOP) at the Screening visit of >18 and not exceeding 36 mmHg.
Diagnosed with primary open angle glaucoma (POAG).
Exclusion
Exclusion Criteria:
- Any of the following prior ocular procedures:
Laser trabeculoplasty ≤180 days prior to baseline
Durysta ≤12 months prior to baseline unless failure is documented and topicalmedication including a prostaglandin analog is in use as per Inclusioncriterion # 3.
Implanted with iStent (All types), Cypass, Xen, Express, glaucoma drainingdevice/valve, or Hydrus Device; or
Prior canaloplasty, goniotomy, trabeculotomy, trabeculectomy, endoscopiccyclophotocoagulation (ECP), Cyclophotocoagulation or CPC (G probe)
Retinal laser procedure ≤3 months prior to baseline
Concurrent IOP-lowering procedure other than the study procedure (OSS) (e.g. ECP,CPC,etc.)
Forms of glaucoma other than POAG including but not limited to: Pigmentary,pseudoexfoliative, acute angle closure, normal tension, pre-perimetric, traumatic,congenital, malignant, uveitic, neovascular or severe glaucoma as documented insubject's medical record.
Women of childbearing potential if they are currently pregnant or intend to becomepregnant during the study period; are breast-feeding; or are not in agreement to useadequate birth control methods to prevent pregnancy throughout the study
Study Design
Study Description
Connect with a study center
North Bay Eye Associates
Petaluma, California 94954
United StatesSite Not Available
University Eye Specialists
Maryville, Tennessee 37803
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.